// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























206 Abstracts

Acute Myelopathy Due to Intracranial Dural Arterio-Venous Fistula: A Case Report.

Abinayaa Ravichandran - American Academy of Neurology (AAN) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

N/A

Cervico Thoracic Spinal Dural Arteriovenous Fistula in a Patient with Lower Extremity Weakness Exacerbated by Steroids and Lumbar Puncture

Sukhraj Gill - American Academy of Neurology (AAN) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

Methylprednisolone

Cushing disease in patient with chronic renal failure treated by hemodialysis: a case report

Ameni Terzi - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Arteriovenous fistula

Dexamethasone

Impact of Arteriovenous Fistula and Non-Physiological Flow States in the Evaluation of Aortic Stenosis Among End-Stage Kidney Disease Patients on Dialysis

Fredrick Ogugua - American Heart Association (AHA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

N/A

ASCENDING AORTIC STRAIN AS A NEW PREDICTOR OF MATURATION IN THE NEWLY CREATED HEMODIALYSIS ARTERIOVENOUS FISTULA

Jong Wook Beom - American College of Cardiology (ACC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

N/A

Benefits Of Supraclavicular Block For Percutaneous Endovascular Arteriovenous Fistula Creation

Paige Schroder - American Society of Anesthesiologists (ASA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

Ropivacaine

Dialysis access usage in recipients of living donor kidney transplants

Mason Lai - National Kidney Foundation (NKF) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

N/A

Iatrogenic Arteriovenous Fistula with Central Venous Catheterization

Charis Whitney - National Kidney Foundation (NKF) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

Bumetanide

Outcome of neonates with severe cardiac failure due to cerebral arteriovenous fistula

Marie-Coralie Cornet - Pediatric Academic Societies (PAS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

N/A

APROMINENT “V” AT ELBOW IS A PREDICTOR OF SUCCESSFUL MEDIAN BASILIC TO BRACHIAL ARTERY ARTERIOVENOUS FISTULA

S. BARNELA - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

N/A

REASONS FOR DIALYSIS CATHETER INSERTION – REAL TIME DATA FROM THE REDUCCTION PROJECT

S. Kotwal - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Arteriovenous fistula

N/A

IMPACT OF ANAESTHESIA ON PROSPECTIVE OUTCOMES AFTER THE CREATION OF ARTERIOVENOUS FISTULA

R. HU - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

N/A

ARTERIOVENOUS FISTULA OUTCOMES AND PREDICTORS OF PRIMARY FAILURE: SINGLE CENTRE EXPERIENCE IN A NEW ZEALAND MAORI AND PASIFIKA PREDOMINANT COHORT

F. NGWENYA - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

N/A

Fundamental study of arteriovenous fistula blood flow using transit time flow measurement

S. HASHIMOTO - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

Papacon

COMBINED DISPLACER-ENHANCED REMOVAL OF PROTEIN-BOUND UREMIC TOXINS ESTIMATED IN SPENT DIALYSATE

A. Adoberg - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

furosemide GR

COMPARISON THE EFFICACY OF SIDE-TO-SIDE AND END-TO-SIDE ANASTOMOSIS FOR ARTERIOVENOUS FISTULA FORMATION IN END STAGE RENAL DISEASE PATIENTS

Y. Zhong - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

N/A

A Single Center Experience With the Safety and Feasibility of Concomitant Atrial Fibrillation Ablation and Left Atrial Appendage Occlusion Six-Month Outcomes

Ashraf Alzahrani - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Arteriovenous fistula

N/A

THE EFFECT OF ARTERIO-VENOUS FISTULA ON THE LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH END-STAGE RENAL DISEASE

John Leso - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Arteriovenous fistula

N/A

AN INDOLENT CAUSE OF HIGH-OUTPUT HEART FAILURE IN END-STAGE KIDNEY DISEASE: APPLICATION OF THE NICOLADONI-ISRAEL-BRANHAM TEST

Fredrick Ogugua - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Arteriovenous fistula

N/A

A THRILL LINKED TO A LARGE ARTERIOVENOUS FISTULA: A HIDDEN CAUSE OF HIGH OUTPUT CARDIAC FAILURE

Ameesh Isath - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arteriovenous fistula

Milrinone

Copyright © 2026. QuantiNova All rights reserved